Fig. 5

Kaplan-Meier analysis of overall survival in patients with stage IV melanoma. Median not reached in IFX or CS group. Median follow-up 26 months
Kaplan-Meier analysis of overall survival in patients with stage IV melanoma. Median not reached in IFX or CS group. Median follow-up 26 months